Expertise in
3
conditions

Shiro Saito

Kamakura, JP 
Expertise in
3
conditions
Kamakura, JP 

Overview

Shiro Saito practices practicing medicine in Kamakura, Japan.

Mr. Saito is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Chondroma, Prostate Cancer, Adult Soft Tissue Sarcoma, Bone Graft, and Prostatectomy.

He is actively involved in clinical research, co-authoring 94 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Kamakura, Japan
Other Locations
Ofuna, Japan
Nagoya, Japan
Tokyo, Japan
Atsugi, 2430198, Japan
Okazaki, 4488650, Japan
Kanazawa, Japan
Meguro, Japan
Meguro, Japan
Gifu-shi, 5011193, Japan
Higashigaoka, 1528902, Japan
Kumamoto, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Japanese Research for Patients With Non-metastatic Castration Resistant Prostate Cancer - Enzalutamide
Japanese Research for Patients With Non-metastatic Castration Resistant Prostate Cancer - Enzalutamide
Enrollment Status: Completed
Publish Date: May 25, 2022
Intervention Type: Drug
Study Phase: Not Applicable

94 Total Publications

Prognostic Impact and Metastasis Propensity of Grade Group 5 Prostate Cancer Following Permanent Seed Implantation Brachytherapy-Based Trimodality Therapy: Implications for Intensified Staging and Systemic Therapy Optimization.
Prognostic Impact and Metastasis Propensity of Grade Group 5 Prostate Cancer Following Permanent Seed Implantation Brachytherapy-Based Trimodality Therapy: Implications for Intensified Staging and Systemic Therapy Optimization.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: February 28, 2026

Frequently Asked Questions about Shiro Saito

Is Shiro Saito a top-rated expert for Chondroma?

MediFind is an objective health platform that identifies experts based on real-world data. Shiro Saito is classified as an Advanced expert for Chondroma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Shiro Saito participate in research or clinical trials?

Yes. Shiro Saito has published 94 articles and abstracts on conditions like Chondroma. You can view a list of Shiro Saito's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Saito's expertise for a condition
ConditionClose
      View All 14 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile